Insperity (NYSE:NSP) Updates FY 2024 Earnings Guidance

Insperity (NYSE:NSP) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 3.420-3.660 for the period, compared to the consensus estimate of 3.580. The company issued revenue guidance of -. Insperity also updated its Q4 2024 guidance to -0.100-0.120 EPS.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. JPMorgan Chase & Co. started coverage on shares of Insperity in a research note on Tuesday, October 22nd. They issued an “underweight” rating and a $90.00 price objective on the stock. William Blair lowered Insperity from an “outperform” rating to a “market perform” rating in a report on Tuesday, September 24th. Finally, Truist Financial decreased their price target on shares of Insperity from $95.00 to $88.00 and set a “hold” rating on the stock in a research note on Friday. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $95.67.

Insperity Stock Down 4.6 %

Shares of NYSE NSP traded down $3.59 during mid-day trading on Friday, hitting $75.18. The company had a trading volume of 616,181 shares, compared to its average volume of 274,986. Insperity has a 1-year low of $74.32 and a 1-year high of $119.40. The company has a market capitalization of $2.82 billion, a PE ratio of 17.73, a price-to-earnings-growth ratio of 2.24 and a beta of 1.11. The company has a debt-to-equity ratio of 2.60, a current ratio of 1.17 and a quick ratio of 1.17. The business’s 50-day simple moving average is $87.39 and its 200 day simple moving average is $94.05.

Insperity (NYSE:NSP) last announced its quarterly earnings results on Thursday, August 1st. The business services provider reported $0.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.72 by $0.14. Insperity had a return on equity of 138.16% and a net margin of 2.46%. The company had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.62 billion. During the same period in the previous year, the business earned $0.33 EPS. Insperity’s revenue for the quarter was up 1.3% on a year-over-year basis. On average, analysts predict that Insperity will post 2.42 earnings per share for the current year.

Insperity Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 19th. Stockholders of record on Thursday, September 5th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Thursday, September 5th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 3.19%. Insperity’s dividend payout ratio (DPR) is presently 56.60%.

Insiders Place Their Bets

In other Insperity news, CEO Paul J. Sarvadi sold 16,123 shares of the stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $92.23, for a total value of $1,487,024.29. Following the completion of the transaction, the chief executive officer now owns 509,129 shares in the company, valued at approximately $46,956,967.67. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 5.50% of the stock is owned by insiders.

About Insperity

Insperity, Inc engages in the provision of human resources (HR) and business solutions to improve business performance for small and medium-sized businesses primarily in the United States. It offers its HR services through its workforce optimization and workforce synchronization solutions that include a range of human resources functions, such as payroll and employment administration, employee benefits, workers' compensation, government compliance, performance management, and training and development services.